Matches in SemOpenAlex for { <https://semopenalex.org/work/W4244783071> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4244783071 endingPage "679" @default.
- W4244783071 startingPage "679" @default.
- W4244783071 abstract "8 Objectives: A proinflammatory nuclear factor, CCAAT/enhancer-binding protein (C/EBP), regulates transcription of the genes including IL-6, platelet-derived growth factor α-receptor (PDGFαR), leptin, COX-2 and IGF-1 which are closely associated with hypertension, atherosclerosis and insulin resistance. The aim of this study is to investigate the effect of peroxisome proliferator-activated receptor (PPAR)γ activation on cytokine-induced IL-6 and PDGFαR expression, and to clarify underlying mechanisms of the action in vascular smooth muscle cells (VSMCs). Methods and Results: Rat cultured VSMCs were pretreated with troglitazone (TRO) (0-10 μM) or 15-deoxy- 12,14 Δ-prostaglandin J 2 (PGJ 2 ) (0-5 μM) for 24 h, and then stimulated by IL-1β(10 ng/mL) for 6 h. While IL-1β alone markedly induced both protein and mRNA levels of IL-6 and PDGFαR, TRO or PGJ 2 significantly inhibited this induction in a dose-dependent manner. Cell proliferation activity was assessed by measurement of BrdU incorporation after treatment with PDGF. PDGF (20 ng/mL) significantly enhanced cell proliferation activity in IL-1β-stimulated cells whereas this enhanced effect was lost by pretreatment with TRO or PGJ 2 almost completely. Further, electromobility shift assay (EMSA) and supershift assay were performed for a C/EBP binding site that mainly regulates IL-6 and PDGFαR genes transcription. EMSA revealed that IL-1β markedly increased DNA-protein complex formation, and pretreatment with TRO or PGJ 2 reduced it almost completely. Supershift assay demonstrated that the retarded band seen in EMSA was supershifted by antibodies against C/EBPδ. On the other hand, TRO or PGJ 2 significantly suppressed IL-1β-induced C/EBPδ expression, and prostaglandin F 2 α, that acts as an inhibitor of PPARγ, diminished the suppressive effect of PPARγ activators on C/EBPδ expression. Conclusions: The effect of PPARγ activation on IL-6 and PDGFαR expression is mediated by suppression of C/EBPδ expression. These results suggest that cross-regulation of PPARγ and C/EBPδ is beneficial to events of vascular inflammation and resultant vascular remodeling." @default.
- W4244783071 created "2022-05-12" @default.
- W4244783071 creator A5050534760 @default.
- W4244783071 creator A5085201867 @default.
- W4244783071 creator A5089313387 @default.
- W4244783071 date "2000-10-01" @default.
- W4244783071 modified "2023-09-29" @default.
- W4244783071 title "PPARγ Activation Inhibits Il-6 and PDGF α-Receptor Expression Via a Nuclear Cofactor C/EBPδ in Vascular Smooth Muscle Cells." @default.
- W4244783071 doi "https://doi.org/10.1161/hyp.36.suppl_1.679-d" @default.
- W4244783071 hasPublicationYear "2000" @default.
- W4244783071 type Work @default.
- W4244783071 citedByCount "0" @default.
- W4244783071 crossrefType "journal-article" @default.
- W4244783071 hasAuthorship W4244783071A5050534760 @default.
- W4244783071 hasAuthorship W4244783071A5085201867 @default.
- W4244783071 hasAuthorship W4244783071A5089313387 @default.
- W4244783071 hasConcept C104317684 @default.
- W4244783071 hasConcept C126322002 @default.
- W4244783071 hasConcept C134018914 @default.
- W4244783071 hasConcept C153911025 @default.
- W4244783071 hasConcept C170493617 @default.
- W4244783071 hasConcept C180361614 @default.
- W4244783071 hasConcept C183978625 @default.
- W4244783071 hasConcept C2775960820 @default.
- W4244783071 hasConcept C2779395532 @default.
- W4244783071 hasConcept C2992686903 @default.
- W4244783071 hasConcept C55493867 @default.
- W4244783071 hasConcept C71924100 @default.
- W4244783071 hasConcept C86339819 @default.
- W4244783071 hasConcept C86803240 @default.
- W4244783071 hasConceptScore W4244783071C104317684 @default.
- W4244783071 hasConceptScore W4244783071C126322002 @default.
- W4244783071 hasConceptScore W4244783071C134018914 @default.
- W4244783071 hasConceptScore W4244783071C153911025 @default.
- W4244783071 hasConceptScore W4244783071C170493617 @default.
- W4244783071 hasConceptScore W4244783071C180361614 @default.
- W4244783071 hasConceptScore W4244783071C183978625 @default.
- W4244783071 hasConceptScore W4244783071C2775960820 @default.
- W4244783071 hasConceptScore W4244783071C2779395532 @default.
- W4244783071 hasConceptScore W4244783071C2992686903 @default.
- W4244783071 hasConceptScore W4244783071C55493867 @default.
- W4244783071 hasConceptScore W4244783071C71924100 @default.
- W4244783071 hasConceptScore W4244783071C86339819 @default.
- W4244783071 hasConceptScore W4244783071C86803240 @default.
- W4244783071 hasIssue "suppl_1" @default.
- W4244783071 hasLocation W42447830711 @default.
- W4244783071 hasOpenAccess W4244783071 @default.
- W4244783071 hasPrimaryLocation W42447830711 @default.
- W4244783071 hasRelatedWork W1993367266 @default.
- W4244783071 hasRelatedWork W2033166621 @default.
- W4244783071 hasRelatedWork W2034583712 @default.
- W4244783071 hasRelatedWork W2063619316 @default.
- W4244783071 hasRelatedWork W2085091660 @default.
- W4244783071 hasRelatedWork W2096890286 @default.
- W4244783071 hasRelatedWork W2126532023 @default.
- W4244783071 hasRelatedWork W2322404450 @default.
- W4244783071 hasRelatedWork W2598342330 @default.
- W4244783071 hasRelatedWork W4244783071 @default.
- W4244783071 hasVolume "36" @default.
- W4244783071 isParatext "false" @default.
- W4244783071 isRetracted "false" @default.
- W4244783071 workType "article" @default.